oral semaglutide approval US FDA accepts Novo Nordisk's application for Wegovy for weight loss Ozempic Pill Approved by FDA:

The association between estimated average glucose levels and fasting plasma glucose levels

According to the Summary of Product Characteristics (SmPCs), GLP-1 medications commonly cause nausea (reported in approximately 20-40% of patients with semaglutide and 12-21% with dulaglutide), vomiting, and diarrhoea, particularly during initial treatment and dose escalation

Known as exendin, the peptide was similar in structure and function to GLP-1but only when glucose is high (think: right after a meal)

Desert Tu cuerpo puede retener ms agua de lo habitual por varias razones, te sientes hinchado y pesado

There are many treatment options also available